173 related articles for article (PubMed ID: 32367204)
1. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract][Full Text] [Related]
2. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Prasad SR; Kumar TSS; Jayakrishnan A
Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
[TBL] [Abstract][Full Text] [Related]
3. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
5. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
[TBL] [Abstract][Full Text] [Related]
6. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
7. Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting.
Ghorbani M; Hamishehkar H
Int J Pharm; 2017 Mar; 520(1-2):126-138. PubMed ID: 28167261
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
9. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
10. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
[TBL] [Abstract][Full Text] [Related]
11. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
12. A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation.
Nozohouri S; Salehi R; Ghanbarzadeh S; Adibkia K; Hamishehkar H
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():752-761. PubMed ID: 30889750
[TBL] [Abstract][Full Text] [Related]
13. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and apoptosis of nanoparticles on osteosarcoma cells using doxorubicin and methotrexate: A systematic review.
Maleki M; Golchin A; Alemi F; Younesi S; Asemi Z; Javadi S; Khiavi PA; Soleinmapour J; Yousefi B
Eur J Pharmacol; 2021 Aug; 904():174131. PubMed ID: 33933464
[TBL] [Abstract][Full Text] [Related]
15. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.
Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
17. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
19. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
